TrialCirculation2022

Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial.

Javed Butler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.